These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25838394)

  • 21. Chemotherapy in heterogeneous cultures of cancer cells with interconversion.
    Dilão R
    Phys Biol; 2014 Nov; 12(1):016002. PubMed ID: 25429401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me'.
    Pisco AO; Huang S
    Br J Cancer; 2015 May; 112(11):1725-32. PubMed ID: 25965164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic regulation of cancer stem cell gene expression.
    Bapat SA
    Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early epigenetic cancer decisions.
    Martín-Lorenzo A; Gonzalez-Herrero I; Rodríguez-Hernández G; García-Ramírez I; Vicente-Dueñas C; Sánchez-García I
    Biol Chem; 2014 Nov; 395(11):1315-20. PubMed ID: 25205718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
    Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
    Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poised epigenetic states and acquired drug resistance in cancer.
    Brown R; Curry E; Magnani L; Wilhelm-Benartzi CS; Borley J
    Nat Rev Cancer; 2014 Nov; 14(11):747-53. PubMed ID: 25253389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic changes in cancer.
    Iacobuzio-Donahue CA
    Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.
    Stindl R
    Med Hypotheses; 2008; 71(1):126-40. PubMed ID: 18294777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of apoptosis pathways in cancer stem cells.
    Fulda S
    Cancer Lett; 2013 Sep; 338(1):168-73. PubMed ID: 22429999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulation of cancer stem cells: Shedding light on the refractory/relapsed cancers.
    Xu L; Zhang J; Sun J; Hou K; Yang C; Guo Y; Liu X; Kalvakolanu DV; Zhang L; Guo B
    Biochem Pharmacol; 2022 Aug; 202():115110. PubMed ID: 35640714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation therapy for solid tumors.
    Xu WP; Zhang X; Xie WF
    J Dig Dis; 2014 Apr; 15(4):159-65. PubMed ID: 24373518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cells in solid tumors: an overview.
    O'Brien CA; Kreso A; Dick JE
    Semin Radiat Oncol; 2009 Apr; 19(2):71-7. PubMed ID: 19249644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of non-genetic heterogeneity on cancer cell death.
    Inde Z; Dixon SJ
    Crit Rev Biochem Mol Biol; 2018 Feb; 53(1):99-114. PubMed ID: 29250983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to chemotherapy: short-term drug tolerance and stem cell-like subpopulations.
    Basile KJ; Aplin AE
    Adv Pharmacol; 2012; 65():315-34. PubMed ID: 22959030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cells: constantly evolving and functionally heterogeneous therapeutic targets.
    Yang T; Rycaj K; Liu ZM; Tang DG
    Cancer Res; 2014 Jun; 74(11):2922-7. PubMed ID: 24713433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cell density and intratumoral heterogeneity in multidrug resistance.
    Lavi O; Greene JM; Levy D; Gottesman MM
    Cancer Res; 2013 Dec; 73(24):7168-75. PubMed ID: 24163380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability.
    Hayford CE; Tyson DR; Robbins CJ; Frick PL; Quaranta V; Harris LA
    PLoS Biol; 2021 Jun; 19(6):e3000797. PubMed ID: 34061819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior.
    Kumar VE; Nambiar R; De Souza C; Nguyen A; Chien J; Lam KS
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-renewal of tumor cells: epigenetic determinants of the cancer stem cell phenotype.
    Ravasio R; Ceccacci E; Minucci S
    Curr Opin Genet Dev; 2016 Feb; 36():92-9. PubMed ID: 27153353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linking metabolism to epigenetics in stem cells and cancer stem cells.
    Chen F
    Semin Cancer Biol; 2019 Aug; 57():iii-v. PubMed ID: 31078639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.